| Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1267-1288, 2018 | 666 | 2018 |
| Amyotrophic lateral sclerosis EL Feldman, SA Goutman, S Petri, L Mazzini, MG Savelieff, PJ Shaw, ... The Lancet 400 (10360), 1363-1380, 2022 | 550 | 2022 |
| Trial of sodium phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis S Paganoni, EA Macklin, S Hendrix, JD Berry, MA Elliott, S Maiser, ... New England Journal of Medicine 383 (10), 919-930, 2020 | 550 | 2020 |
| Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis SA Goutman, O Hardiman, A Al-Chalabi, A Chió, MG Savelieff, ... The Lancet Neurology 21 (5), 480-493, 2022 | 281 | 2022 |
| Painful diabetic neuropathy A Peltier, SA Goutman, BC Callaghan Bmj 348, 2014 | 275 | 2014 |
| Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis SA Goutman, O Hardiman, A Al-Chalabi, A Chió, MG Savelieff, ... The Lancet Neurology 21 (5), 465-479, 2022 | 269 | 2022 |
| Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era X Paez-Colasante, C Figueroa-Romero, SA Sakowski, SA Goutman, ... Nature Reviews Neurology 11 (5), 266-279, 2015 | 262 | 2015 |
| Long‐term survival of participants in the CENTAUR trial of sodium phenylbutyrate‐taurursodiol in amyotrophic lateral sclerosis S Paganoni, S Hendrix, SP Dickson, N Knowlton, EA Macklin, JD Berry, ... Muscle & nerve 63 (1), 31-39, 2021 | 197 | 2021 |
| Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression BJ Murdock, T Zhou, SR Kashlan, RJ Little, SA Goutman, EL Feldman JAMA neurology 74 (12), 1446-1454, 2017 | 189 | 2017 |
| Association of environmental toxins with amyotrophic lateral sclerosis FC Su, SA Goutman, S Chernyak, B Mukherjee, BC Callaghan, ... JAMA neurology 73 (7), 803-811, 2016 | 174 | 2016 |
| Transplantation of spinal cord–derived neural stem cells for ALS: analysis of phase 1 and 2 trials JD Glass, VS Hertzberg, NM Boulis, J Riley, T Federici, M Polak, ... Neurology 87 (4), 392-400, 2016 | 165 | 2016 |
| Environmental risk factors and amyotrophic lateral sclerosis (ALS): a case-control study of ALS in Michigan Y Yu, FC Su, BC Callaghan, SA Goutman, SA Batterman, EL Feldman PloS one 9 (6), e101186, 2014 | 123 | 2014 |
| Effect of ezogabine on cortical and spinal motor neuron excitability in amyotrophic lateral sclerosis: a randomized clinical trial BJ Wainger, EA Macklin, S Vucic, CE McIlduff, S Paganoni, NJ Maragakis, ... JAMA neurology 78 (2), 186-196, 2021 | 122 | 2021 |
| Diagnosis and clinical management of amyotrophic lateral sclerosis and other motor neuron disorders SA Goutman CONTINUUM: Lifelong Learning in Neurology 23 (5), 1332-1359, 2017 | 91 | 2017 |
| Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis BJ Murdock, DE Bender, SR Kashlan, C Figueroa-Romero, C Backus, ... Neurology: Neuroimmunology & Neuroinflammation 3 (4), e242, 2016 | 84 | 2016 |
| Pathogenic huntingtin repeat expansions in patients with frontotemporal dementia and amyotrophic lateral sclerosis R Dewan, R Chia, J Ding, RA Hickman, TD Stein, Y Abramzon, S Ahmed, ... Neuron 109 (3), 448-460. e4, 2021 | 81 | 2021 |
| Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR … S Paganoni, S Hendrix, SP Dickson, N Knowlton, JD Berry, MA Elliott, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (8), 871-875, 2022 | 74 | 2022 |
| Untargeted metabolomics yields insight into ALS disease mechanisms SA Goutman, J Boss, K Guo, FM Alakwaa, A Patterson, S Kim, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (12), 1329-1338, 2020 | 72 | 2020 |
| Adaptive platform trials to transform amyotrophic lateral sclerosis therapy development S Paganoni, JD Berry, M Quintana, E Macklin, BR Saville, MA Detry, ... Annals of neurology 91 (2), 165-175, 2022 | 70 | 2022 |
| Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders J Gilley, O Jackson, M Pipis, MA Estiar, A Al-Chalabi, MC Danzi, ... Elife 10, e70905, 2021 | 64 | 2021 |
